Rapamycin Holdings rapamycinholdings.com


Public lists: Pharma Startups (4733)

Rapamycin Holdings licenses rapamycin-related intellectual property developed at the UTHSCSA. Rapamycin, a drug federally approved to suppress organ rejection, continues to be studied for its potential to slow the aging process and its efficacy in treating age-related diseases.

Rapamycin Holdings licenses rapamycin-related intellectual property developed at the UTHSCSA. Rapamycin, a drug federally approved to suppress organ rejection, continues to be studied for its potential to slow the aging process and its efficacy in tr...Show all

Company (Alive / Active)

Phone: 210-381-2486

Fax:

12500 Network Blvd
Suite 105
San Antonio, 78249
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rapamycin Holdings $1.4M Feb 3, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rapamycin Holdings Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Oral rapamycin preparation and use for stomatitis May 20, 2015 Mar 15, 2016 Patent
Oral rapamycin preparation and use for stomatitus Apr 16, 2015 Application
Oral rapamycin nanoparticle preparations and use Dec 31, 2014 Application